281 related articles for article (PubMed ID: 25137236)
21. Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE).
Arden NK; Lloyd ME; Spector TD; Hughes GR
Lupus; 1994 Feb; 3(1):11-3. PubMed ID: 8025579
[TBL] [Abstract][Full Text] [Related]
22. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus.
Sanchez-Guerrero J; Karlson EW; Liang MH; Hunter DJ; Speizer FE; Colditz GA
Arthritis Rheum; 1997 May; 40(5):804-8. PubMed ID: 9153539
[TBL] [Abstract][Full Text] [Related]
23. Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review.
Culwell KR; Curtis KM; Del Carmen Cravioto M
Obstet Gynecol; 2009 Aug; 114(2 Pt 1):341-353. PubMed ID: 19622996
[TBL] [Abstract][Full Text] [Related]
24. Estrogen in cardiovascular disease during systemic lupus erythematosus.
Gilbert EL; Ryan MJ
Clin Ther; 2014 Dec; 36(12):1901-1912. PubMed ID: 25194860
[TBL] [Abstract][Full Text] [Related]
25. Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus.
Mok CC; Lau CS; Ho CT; Lee KW; Mok MY; Wong RW
Scand J Rheumatol; 1998; 27(5):342-6. PubMed ID: 9808396
[TBL] [Abstract][Full Text] [Related]
26. [Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus].
Pozsonyi T; Jakab L; Jakab L; Onody K; Cseh K; Kalabay L
Orv Hetil; 1992 May; 133(19):1167-71. PubMed ID: 1584598
[TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
28. [Systemic lupus erythematosus and contraception: A systematic literature review].
Gensous N; Doassans-Comby L; Lazaro E; Duffau P
Rev Med Interne; 2017 Jun; 38(6):358-367. PubMed ID: 28161112
[TBL] [Abstract][Full Text] [Related]
29. Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE.
Julkunen HA
Scand J Rheumatol; 1991; 20(6):427-33. PubMed ID: 1771400
[TBL] [Abstract][Full Text] [Related]
30. Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: A systematic review and meta-analysis.
Wang S; Wang Y; Xu J; Chen Y
Medicine (Baltimore); 2017 Apr; 96(14):e6556. PubMed ID: 28383429
[TBL] [Abstract][Full Text] [Related]
31. Oral contraceptives and systemic lupus erythematosus.
Petri M; Robinson C
Arthritis Rheum; 1997 May; 40(5):797-803. PubMed ID: 9153538
[TBL] [Abstract][Full Text] [Related]
32. The influence of endogenous and exogenous sex hormones on systemic lupus erythematosus in pre- and postmenopausal women.
Grygiel-Górniak B; Puszczewicz MJ
Prz Menopauzalny; 2014 Sep; 13(4):262-6. PubMed ID: 26327864
[TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease.
Hochman J; Urowitz MB; Ibañez D; Gladman DD
Lupus; 2009 Apr; 18(4):313-7. PubMed ID: 19276299
[TBL] [Abstract][Full Text] [Related]
34. Oral contraceptives and the risk of subarachnoid hemorrhage: a meta-analysis.
Johnston SC; Colford JM; Gress DR
Neurology; 1998 Aug; 51(2):411-8. PubMed ID: 9710012
[TBL] [Abstract][Full Text] [Related]
35. Antiestrogen antibodies, oral contraception and systemic lupus erythematosus.
Beaumont V; Gioud-Paquet M; Kahn MF; Beaumont JL
Clin Physiol Biochem; 1989; 7(5):263-8. PubMed ID: 2805575
[TBL] [Abstract][Full Text] [Related]
36. Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis.
Zuily S; Domingues V; Suty-Selton C; Eschwège V; Bertoletti L; Chaouat A; Chabot F; Regnault V; Horn EM; Erkan D; Wahl D
Autoimmun Rev; 2017 Jun; 16(6):576-586. PubMed ID: 28411166
[TBL] [Abstract][Full Text] [Related]
37. Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review.
Soares-Jr JM; Espósito Sorpreso IC; Nunes Curado JF; Ferreira Filho ES; Dos Santos Simões R; Bonfá E; Silva CA; Baracat EC
Climacteric; 2022 Oct; 25(5):427-433. PubMed ID: 35438053
[TBL] [Abstract][Full Text] [Related]
38. Contraceptive practice in women with systemic lupus erythematosus.
Julkunen HA; Kaaja R; Friman C
Br J Rheumatol; 1993 Mar; 32(3):227-30. PubMed ID: 8448613
[TBL] [Abstract][Full Text] [Related]
39. Suicidal behavior in patients with systematic lupus erythematosus: Systematic literature review and genetic linkage disequilibrium analysis.
Parperis K; Kyriakou A; Voskarides K; Chatzittofis A
Semin Arthritis Rheum; 2022 Jun; 54():151997. PubMed ID: 35344734
[TBL] [Abstract][Full Text] [Related]
40. Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy.
Koomen ER; Joosse A; Herings RM; Casparie MK; Guchelaar HJ; Nijsten T
Melanoma Res; 2009 Oct; 19(5):327-32. PubMed ID: 19593232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
